Intellia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 51 | 0.0% | 5,629 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 72 | 0.0% | 4,150 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 38 | 0.0% | 4,001 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 28 | 0.0% | 3,464 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 41 | 0.0% | 3,394 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 77 | 0.0% | 3,674 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 67 | 0.0% | 2,880 | 6/30/2024 |
| 2024 Q1 | 5/1/2024 | 7,728 | 0.0% | 217,394 | 3/31/2024 |
| 2023 Q4 | 1/24/2024 | 5,667 | 0.0% | 185,858 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 9,067 | 0.0% | 286,743 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 10,771 | 0.0% | 264,110 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 8,115 | 0.0% | 217,729 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 7,267 | 0.0% | 208,271 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 11,831 | 0.0% | 211,423 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 9,292 | 0.0% | 179,525 | 6/30/2022 |
| 2022 Q1 | 5/10/2022 | 5,514 | 0.0% | 75,874 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 10,592 | 0.0% | 89,581 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 18,648 | 0.0% | 139,015 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 18,279 | 0.1% | 112,902 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 8,933 | 0.0% | 111,298 | 3/31/2021 |
| 2020 Q4 | 2/10/2021 | 3,307 | 0.0% | 60,802 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 738 | 0.0% | 37,102 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 532 | 0.0% | 25,307 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 191 | 0.0% | 15,656 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 205 | 0.0% | 13,954 | 12/31/2019 |